Paul Hjemdahl
-
- Heart Rate Variability and Autonomic Control 76
- Antiplatelet Therapy and Cardiovascular Diseases 64
- Atrial Fibrillation Management and Outcomes 32
- Blood Pressure and Hypertension Studies 27
- Internal Medicine top 0.5%
- Behavioral Neuroscience top 0.5%
-
- Cardiovascular and exercise physiology 29
-
- Lipoproteins and Cardiovascular Health 28
-
- Platelet Disorders and Treatments 24
-
- Neuropeptides and Animal Physiology 21
- Co-authors
- Thomas KahanNailin LiN. Håkan WallénMaud DaleskogBirgitta LindeP. T. LarssonAlison H. GoodallNina Rehnqvist
- Journals
- Circulation (5 papers)Journal of Clinical Investigation (1 paper)Journal of the American College of Cardiology (1 paper)
- Partner nations
- SwedenUnited KingdomNetherlands
In The Last Decade
Paul Hjemdahl
355 papers receiving 11.2k citations
Hit Papers
Peers
Comparison fields: 5 of 156
- Cardiology and Cardiovascular Medicine 5.8k
- Internal Medicine 845
- Behavioral Neuroscience 561
- Complementary and alternative medicine 908
- Endocrine and Autonomic Systems 584
Countries citing papers authored by Paul Hjemdahl
This map shows the geographic impact of Paul Hjemdahl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Hjemdahl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Hjemdahl more than expected).
Fields of papers citing papers by Paul Hjemdahl
This network shows the impact of papers produced by Paul Hjemdahl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Hjemdahl. The network helps show where Paul Hjemdahl may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Paul Hjemdahl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 0 | |
| 4 | Lessons from 20 years with COX‐2 inhibitors: Importance of dose–response considerations and fair play in comparative trialsbreakdown → | 2022 | 99 |
| 5 | 2022 | 29 | |
| 6 | 2022 | 24 | |
| 7 | 2021 | 24 | |
| 8 | 2020 | 35 | |
| 9 | 2019 | 11 | |
| 10 | 2014 | 42 | |
| 11 | 2006 | 64 | |
| 12 | 2003 | 35 | |
| 13 | The effects of adenosine as adjuvant therapy in acute myocardial infarction on cardiovascular events. Results of the ATTenuation by Adenosine of Cardiac Complications (ATTACC) study | 2001 | 2 |
| 14 | 1998 | 15 | |
| 15 | 1996 | 14 | |
| 16 | Treatment of stable angina pectoris with calcium antagonists and beta-blockers : The APSIS study | 1995 | 12 |
| 17 | 1993 | 8 | |
| 18 | 1992 | 9 | |
| 19 | 1988 | 13 | |
| 20 | Influence of beta-adrenoceptor blockade by metoprolol and propranolol on plasma concentrations and effects of noradrenaline and adrenaline during i.v. infusion. | 1983 | 59 |
About Paul Hjemdahl
Paul Hjemdahl is a scholar working on Cardiology and Cardiovascular Medicine, Behavioral Neuroscience and Internal Medicine, having authored 359 papers that have together received 11.7k indexed citations. Recurring topics across this work include Heart Rate Variability and Autonomic Control (76 papers), Antiplatelet Therapy and Cardiovascular Diseases (64 papers), Atrial Fibrillation Management and Outcomes (32 papers), Cardiovascular and exercise physiology (29 papers), Lipoproteins and Cardiovascular Health (28 papers), Blood Pressure and Hypertension Studies (27 papers), Platelet Disorders and Treatments (24 papers) and Neuropeptides and Animal Physiology (21 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (5.8k citations), Internal Medicine (845 citations) and Behavioral Neuroscience (561 citations). Paul Hjemdahl has collaborated with scholars based in Sweden, United Kingdom and Netherlands. Frequent co-authors include Thomas Kahan, Nailin Li, N. Håkan Wallén, Maud Daleskog, Birgitta Linde, P. T. Larsson, Alison H. Goodall, Nina Rehnqvist, Arne Martinsson and Björn Wettermark. Their work appears in journals such as Circulation, Journal of Clinical Investigation and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.